##gff-version 3
##sequence-region P52952 1 324
P52952	UniProtKB	Chain	1	324	.	.	.	ID=PRO_0000048937;Note=Homeobox protein Nkx-2.5	
P52952	UniProtKB	DNA binding	138	197	.	.	.	Note=Homeobox;Ontology_term=ECO:0000255,ECO:0000269,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00108,ECO:0000269|PubMed:22849347,ECO:0000269|PubMed:26926761;Dbxref=PMID:22849347,PMID:26926761	
P52952	UniProtKB	Compositional bias	42	108	.	.	.	Note=Ala/Pro-rich	
P52952	UniProtKB	Compositional bias	208	282	.	.	.	Note=Ala/Pro-rich	
P52952	UniProtKB	Alternative sequence	112	151	.	.	.	ID=VSP_043492;Note=In isoform 2. ELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVY->GCELPRGQRPPVLFSSALSQPDFLQMLSETCRWLPVHLAE;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P52952	UniProtKB	Alternative sequence	112	112	.	.	.	ID=VSP_045481;Note=In isoform 3. E->A;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P52952	UniProtKB	Alternative sequence	113	324	.	.	.	ID=VSP_045482;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P52952	UniProtKB	Alternative sequence	152	324	.	.	.	ID=VSP_043493;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P52952	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_038212;Note=In ASD7%3B somatic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_038213;Note=In ASD7. K->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs387906773,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_049581;Note=D->A;Dbxref=dbSNP:rs17052019	
P52952	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_038214;Note=In ASD7%3B somatic mutation. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_038215;Note=In TOF and ASD7. E->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11714651,ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs104893904,PMID:11714651,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_038216;Note=In ASD7 and TOF. Q->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs201442000,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_010116;Note=In ASD7%2C TOF%2C CHNG5%2C HLHS2 and CTHM%3B unknown pathological significance%3B exhibits significant functional impairment with reduction of transactivation properties and dominant-negative effect%3B the mutant protein activity on the DIO2%2C TG and TPO promoters is significantly impaired. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587520,ECO:0000269|PubMed:11714651,ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15342699,ECO:0000269|PubMed:15810002,ECO:0000269|PubMed:16418214,ECO:0000269|PubMed:17891434;Dbxref=dbSNP:rs28936670,PMID:10587520,PMID:11714651,PMID:14607454,PMID:15342699,PMID:15810002,PMID:16418214,PMID:17891434	
P52952	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_038217;Note=In ASD7%3B somatic mutation. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs779548360,PMID:15342699	
P52952	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_038218;Note=In ASD7%3B somatic mutation. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs753937287,PMID:15342699	
P52952	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_067586;Note=In VSD3%3B significantly reduced activation of NPPA gene compared to wild-type. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21165553;Dbxref=dbSNP:rs387906775,PMID:21165553	
P52952	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_038219;Note=In ASD7. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs530270916,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_038220;Note=In ASD7%3B somatic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_069058;Note=G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702039;Dbxref=dbSNP:rs201362118,PMID:14702039	
P52952	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_038221;Note=In ASD7%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_038222;Note=In ASD7%3B somatic mutation. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_038223;Note=In ASD7%3B somatic mutation. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_038224;Note=In ASD7%3B somatic mutation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_047869;Note=In CHNG5%3B exhibits a significant functional impairment with reduction of transactivation properties and dominant-negative effect which was associated with reduced DNA binding. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16418214;Dbxref=dbSNP:rs137852684,PMID:16418214	
P52952	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_038225;Note=In ASD7%3B somatic mutation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_038226;Note=In ASD7%3B somatic mutation. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_038227;Note=In ASD7. A->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs387906774,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_038228;Note=In ASD7%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs1184594159,PMID:15342699	
P52952	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_038229;Note=In ASD7%3B somatic mutation. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_038230;Note=In ASD7. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15810002;Dbxref=PMID:15810002	
P52952	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_038231;Note=In ASD7%3B somatic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_047870;Note=In CHNG5%3B exhibits a significant functional impairment with reduction of transactivation properties and dominant-negative effect which was associated with reduced DNA binding. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16418214;Dbxref=dbSNP:rs137852685,PMID:16418214	
P52952	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_003752;Note=In ASD7. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15342699,ECO:0000269|PubMed:15810002,ECO:0000269|PubMed:9651244;Dbxref=dbSNP:rs104893900,PMID:15342699,PMID:15810002,PMID:9651244	
P52952	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_038232;Note=In ASD7%3B somatic mutation. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs137852686,PMID:15342699	
P52952	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_038233;Note=In ASD7. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15810002;Dbxref=PMID:15810002	
P52952	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_010117;Note=In ASD7. N->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587520,ECO:0000269|PubMed:15810002;Dbxref=PMID:10587520,PMID:15810002	
P52952	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_010118;Note=In ASD7. R->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587520,ECO:0000269|PubMed:15810002;Dbxref=PMID:10587520,PMID:15810002	
P52952	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_038234;Note=In ASD7. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs104893906,PMID:15810002	
P52952	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_010119;Note=In ASD7. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587520,ECO:0000269|PubMed:15810002;Dbxref=PMID:10587520,PMID:15810002	
P52952	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_038235;Note=In ASD7%3B somatic mutation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_038236;Note=In ASD7%3B somatic mutation. K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_038237;Note=In ASD7%3B somatic mutation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_038238;Note=In ASD7%3B somatic mutation. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_038239;Note=In TOF and ASD7. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11714651,ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs104893905,PMID:11714651,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_038240;Note=In ASD7 and TOF%3B somatic mutation. A->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11714651,ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15342699,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs104893902,PMID:11714651,PMID:14607454,PMID:15342699,PMID:15810002	
P52952	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_038241;Note=In ASD7%3B somatic mutation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs760528062,PMID:15342699	
P52952	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_069590;Note=Found in patients with isolated congenital asplenia%3B unknown pathological significance%3B does not affect DNA binding%3B impairs transactivation activity. P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22560297;Dbxref=dbSNP:rs397515399,PMID:22560297	
P52952	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_038242;Note=In ASD7%3B somatic mutation. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_038243;Note=In ASD7. P->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=dbSNP:rs368366482,PMID:14607454,PMID:15810002	
P52952	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_038244;Note=In ASD7%3B somatic mutation. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs1223599871,PMID:15342699	
P52952	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_038245;Note=In ASD7%3B somatic mutation. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_038246;Note=In ASD7%3B somatic mutation. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_067587;Note=In VSD3. P->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21110066;Dbxref=dbSNP:rs375086983,PMID:21110066	
P52952	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_038247;Note=In ASD7%3B somatic mutation. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_067588;Note=In CTMH. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14607454;Dbxref=PMID:14607454	
P52952	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_038248;Note=In ASD7%3B somatic mutation. N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_038249;Note=In ASD7%3B somatic mutation. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=dbSNP:rs137852683,PMID:15342699	
P52952	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_038250;Note=In ASD7%3B somatic mutation. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_038251;Note=In ASD7%3B somatic mutation. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_038252;Note=In ASD7%3B somatic mutation. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15342699;Dbxref=PMID:15342699	
P52952	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_038253;Note=In ASD7 and TOF. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14607454,ECO:0000269|PubMed:15810002;Dbxref=PMID:14607454,PMID:15810002	
P52952	UniProtKB	Helix	147	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3RKQ	
P52952	UniProtKB	Helix	165	175	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3RKQ	
P52952	UniProtKB	Helix	179	193	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3RKQ	
